Krishna Institute of Medical Sciences is currently trading at Rs. 2132.70, up by 28.85 points or 1.37% from its previous closing of Rs. 2103.85 on the BSE.

The scrip opened at Rs. 2125.00 and has touched a high and low of Rs. 2190.05 and Rs. 2125.00 respectively. So far 7579 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 2357.00 on 29-Feb-2024 and a 52 week low of Rs. 1625.05 on 16-Oct-2023.

Last one week high and low of the scrip stood at Rs. 2169.90 and Rs. 2092.65 respectively. The current market cap of the company is Rs. 17268.40 crore.

The promoters holding in the company stood at 38.82%, while Institutions and Non-Institutions held 49.86% and 11.32% respectively.

Krishna Institute of Medical Sciences (KIMS) is all set to acquire 200-bed multi-specialty hospital at a prime location in Vizag currently operating under the brand name of ‘Queen's NRI Hospital’ (QNRI). 

In this regard, KIMS has inked Share Purchase agreement with the erstwhile promoters and shareholders of Chalasani Hospitals, owners of QNRI, to purchase 100% holding in the company. KIMS already have a multi-specialty hospital and gastro unit at Vizag and this addition will help it garner a larger share in the market. Besides the hospital is situated in a prime locality which makes it an attractive proposition. 

QNRI is a 200-bed hospital at a prime location in Vizag. It was established in 1995 with a built-up area of around 1,50,000 Sq ft. The Hospital is in a densely populated locality with good potential. The nearest hospital is about five and a half km away, and the health city known as New Vizag is around 17 Km away from the location.

Krishna Institute of Medical Sciences offers a comprehensive range of healthcare services including oncology, cardiac sciences, neurosciences, gastric sciences, orthopaedics, renal sciences, organ transplantation, and mother & child care.